Cargando…
Respiratory Syncytial Virus Infection in High-risk Infants – an Update on Palivizumab Prophylaxis
Morbidity due to respiratory syncytial virus (RSV) disease is still high in infants and children worldwide during the first two to five years of life. Certain categories of high-risk infants with increased morbidity and mortality attributed to RSV disease have been identified and are included in nat...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Open
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133922/ https://www.ncbi.nlm.nih.gov/pubmed/25132870 http://dx.doi.org/10.2174/1874285801408010071 |